IOL Chemicals and Pharmaceuticals Limited has submitted to the Exchange, Outcome of the Board Meeting and submission of Un-Audited Financial Results for thequarter and ninemonths ended 31"December 2025
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals and Pharmaceuticals has submitted its unaudited financial results for the third quarter and nine months ending 31 December 2025, following a board meeting. These are interim, un-audited numbers covering both the standalone quarter and the year-to-date period. Specific revenue, profit, and margin figures were not included in the headline and would need to be reviewed in the full results document. As a chemicals and pharmaceuticals manufacturer, the results will reflect performance across its API and specialty chemical segments.
This is a routine quarterly results filing, so the immediate stock impact will depend on whether the numbers beat or miss market expectations. Investors should review the detailed results for revenue growth, margin trends, and profit movements versus the same quarter last year.